Tirzepatide 30mg

Mid-Range Dual GIP/GLP-1 Agonist for Versatile Research

Tirzepatide 30mg is a versatile mid-range dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist designed for flexible metabolic research. This 30mg supply provides researchers with an ideal balance between affordability and sufficient material for comprehensive studies in glucose regulation, weight management, and metabolic health.

Why Researchers Choose Tirzepatide 30mg:

• Versatile Mid-Range Supply: 30mg provides optimal flexibility for various research protocols and experimental designs
• Budget-Conscious Choice: Excellent value for laboratories seeking quality without overcommitting to larger quantities
• Dual Mechanism Innovation: First-in-class dual GIP/GLP-1 receptor agonist for studying synergistic metabolic effects
• Multiple Experiments: Sufficient quantity for several experimental runs and comparative studies
• Enhanced Potency: Superior efficacy compared to single-receptor agonists in preclinical models
• Flexible Research Design: Perfect for both preliminary and follow-up investigations
• Research-Grade Purity: Pharmaceutical-quality peptide (≥98%) for reliable, reproducible outcomes
• Proven Mechanism: Well-documented dual incretin pathway for confident research planning

Ideal Research Applications:

Perfect for laboratories conducting metabolic research with moderate scope, comparative peptide studies, and multi-phase investigations. Tirzepatide 30mg is particularly valuable for researchers who:

• Need flexibility to explore multiple research directions
• Are conducting comparative studies with other metabolic peptides
• Want to validate findings across different experimental conditions
• Require sufficient material for replicate experiments
• Are balancing research ambitions with budget considerations
• Need a reliable supply for ongoing research without excess inventory

Key Research Areas:

• Dual incretin receptor activation and synergistic metabolic effects
• Body weight regulation and appetite suppression mechanisms
• Glucose-dependent insulin secretion and glycemic control
• Satiety signaling and food intake regulation pathways
• Cardiovascular benefits of metabolic interventions
• Beta-cell function and pancreatic health preservation
• Lipid metabolism and hepatic fat accumulation
• Energy expenditure and metabolic rate modulation
• Comparative efficacy studies with other GLP-1 agonists

Technical Specifications:

• Quantity: 30mg (versatile research supply)
• Type: Dual GIP/GLP-1 receptor agonist
• Structure: 39 amino acid synthetic peptide
• Form: Lyophilized powder for reconstitution
• Purity: ≥98% (HPLC verified)
• Molecular Weight: ~4813 Da
• Storage: Store at 2-8°C before reconstitution; -20°C after reconstitution
• Solubility: Reconstitute with bacteriostatic water
• Stability: Enhanced stability profile with C20 fatty acid modification
• Quality: Pharmaceutical-grade for reliable results

Research Advantages:

Tirzepatide represents a breakthrough in incretin-based research, combining GIP and GLP-1 receptor activation to produce superior metabolic outcomes. The 30mg supply provides researchers with a versatile quantity that supports diverse research objectives while maintaining cost-effectiveness.

Unique Mechanism: Unlike single-receptor agonists, Tirzepatide activates both GIP and GLP-1 receptors simultaneously, leading to enhanced insulin secretion, reduced glucagon levels, delayed gastric emptying, and significant appetite suppression. The dual activation creates synergistic effects that exceed the sum of individual receptor stimulation.

Clinical Relevance: Tirzepatide has demonstrated remarkable efficacy in clinical trials, achieving up to 22.5% body weight reduction and superior glycemic control compared to existing treatments. This makes it an essential tool for researchers investigating next-generation metabolic therapeutics.

Optimal for Multi-Phase Research: The 30mg quantity is ideal for researchers conducting multi-phase studies, allowing for initial experiments, protocol refinement, and validation studies without running short or having excessive unused material.

Comparative Research Value: This quantity is perfect for side-by-side comparisons with other metabolic peptides like semaglutide or liraglutide, enabling researchers to understand tirzepatide's unique advantages and mechanisms.

Research Flexibility: With 30mg, researchers can explore multiple dosing regimens, test various experimental conditions, conduct time-course studies, and maintain consistency across research phases while staying within budget.

Quality Assurance: Each batch undergoes rigorous HPLC testing to ensure ≥98% purity, providing you with the confidence needed for publishable research and reproducible results.

Important Disclaimer: This product is sold exclusively for research and laboratory purposes. Not intended for human consumption, therapeutic use, weight loss applications, or veterinary use. For in vitro and animal research only.

*Price per vial.
*This product is in powder form and is not reconstituted.
*For research purposes only.
*Tested at 99% purity.
*Free shipping.
*All sales final.